The Fund announced that shares of the Fund are expected to begin trading on the New York Stock Exchange (“NYSE”) on or about January 13, 2022 under the proposed NYSE ticker symbol “DMA.”
The Fund, which previously operated as a continuously offered closed-end interval fund, is advised by Destra Capital Advisors LLC (“Destra”) and sub-advised by Validus Growth Investors, LLC (“Validus”). The Fund invests in a diversified portfolio of alternative assets and strategies in pursuit of its objective to seek returns from capital appreciation and income with an emphasis on income generation.